Skip to main content

Loading market ticker...

Neuland Laboratories

Healthcare NSE:NEULANDLAB

19542.00INR
653.00 ( 3.46%)

Last update at July 9, 2026, midnight

Day Range

18910.0020089.00
LowHigh

52 Week Range

10182.27 19747.00
LowHigh

Fundamentals

  • Previous Close 18889.00
  • Market Cap 190357.03M
  • Volume97,154
  • P/E Ratio 78.97
  • EBITDA 3287.78M
  • Revenue TTM 15334.18M
  • Revenue Per Share TTM 1195.18
  • Gross Profit TTM 7732.19M
  • Diluted EPS TTM 187.67

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1427.60 15/05/26 15/05/26 Same Day Short Term Healthcare 0.17%
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 3463.29M 4014.37M 2157.46M 821.63M 1053.34M
Net income 2601.08M 3000.79M 1635.18M 638.22M 806.31M
Total Revenue 14768.37M 15585.81M 11608.99M 9233.34M 9242.65M
Gross Profit 7263.29M 8247.84M 5471.13M 3698.32M 3634.58M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 21798.82M 18325.61M 15797.65M 13834.88M 13247.88M
Intangible assets 48.54M 24.58M 13.01M 21.20M 34.98M
Other current assets 715.18M 850.38M 537.60M 552.07M 552.98M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash 443.55M 712.63M 412.39M 26.56M -87.68M
Operating Cash 3173.83M 2556.88M 2385.32M 585.81M 1893.62M
Free Cash Flow 1109.19M 1120.18M 1724.05M -372.97M 839.65M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
NEULANDLAB
Neuland Laboratories 		653.00 3.46% 19542.00 190357.03 78.97
SUNPHARMA
Sun Pharmaceutical Industries Limited 		50.50 2.67% 1938.70 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		58.00 0.86% 6813.00 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		31.80 0.65% 4898.20 1362716.66 63.48
CIPLA
Cipla Limited 		9.50 0.66% 1441.30 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.